Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-05-01
DOI
https://doi.org/10.1136/bmjopen-2024-095508
Citations
2
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
2.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study

Xiongying Jiang, Song Chen, Qifeng Chen, Yue Hu et al.
2 citations
BMJ Open
Hepatocellular Carcinoma Treatment and Prognosis
2.64
article

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study

Xiongying Jiang, Song Chen, Qifeng Chen, Yue Hu, Ning Lyu, Ming Zhao
article en
2 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(5)
Sun Yat-sen University (CN), Sun Yat-sen Memorial Hospital (CN), Sun Yat-sen University Cancer Center (CN)
National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province
Openalex Percentile: Top 10%
Hepatocellular Carcinoma Treatment and Prognosis
2.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.